Jonathan Block
Stock Analyst at Stifel Nicolaus
(4.01)
# 1,755
Out of 4,988 analysts
597
Total ratings
48.6%
Success rate
5%
Average return
Main Sectors:
Stocks Rated by Jonathan Block
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELAN Elanco Animal Health | Reiterated: Buy | n/a | $22.42 | - | 43 | Sep 18, 2026 | |
| NVST Envista Holdings | Reiterated: Buy | $31 | $23.35 | +32.76% | 26 | Sep 18, 2026 | |
| ZTS Zoetis | Reiterated: Hold | n/a | $71.40 | - | 61 | Sep 18, 2026 | |
| BBNX Beta Bionics | Reiterated: Buy | $20 → $22 | $21.89 | +0.50% | 8 | Sep 15, 2026 | |
| COO The Cooper Companies | Reiterated: Buy | $70 | $55.29 | +26.61% | 38 | Sep 13, 2026 | |
| INSP Inspire Medical Systems | Rated: Buy | $75 → $80 | $76.78 | +4.19% | 42 | Sep 13, 2026 | |
| TRUP Trupanion | Reiterated: Hold | $28 → $29 | $25.07 | +15.68% | 45 | Aug 20, 2026 | |
| IDXX IDEXX Laboratories | Reiterated: Buy | $675 | $511.65 | +31.93% | 68 | Aug 14, 2026 | |
| SKIN SkinHealth Systems | Reiterated: Hold | $2 → $1 | $0.675 | +48.15% | 18 | Aug 11, 2026 | |
| TNDM Tandem Diabetes Care | Reiterated: Hold | $22 | $16.87 | +30.41% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $14 | $9.54 | +46.75% | 44 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $225 → $180 | $140.60 | +28.02% | 7 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $84 → $95 | $84.84 | +11.98% | 34 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $90 → $95 | $89.35 | +6.32% | 7 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $210 | $147.61 | +42.27% | 104 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $235 | $224.99 | +4.45% | 11 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $9 → $8 | $9.58 | -16.49% | 4 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $9 | $0.67 | n/a | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $55 → $45 | $163.81 | n/a | 22 | May 8, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $100 | $0.0002 | n/a | 1 | Jul 23, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $41 → $47 | $239.56 | n/a | 3 | May 15, 2017 |
Elanco Animal Health
Sep 18, 2026
Reiterated: Buy
Price Target: n/a
Current: $22.42
Upside: -
Envista Holdings
Sep 18, 2026
Reiterated: Buy
Price Target: $31
Current: $23.35
Upside: +32.76%
Zoetis
Sep 18, 2026
Reiterated: Hold
Price Target: n/a
Current: $71.40
Upside: -
Beta Bionics
Sep 15, 2026
Reiterated: Buy
Price Target: $20 → $22
Current: $21.89
Upside: +0.50%
The Cooper Companies
Sep 13, 2026
Reiterated: Buy
Price Target: $70
Current: $55.29
Upside: +26.61%
Inspire Medical Systems
Sep 13, 2026
Rated: Buy
Price Target: $75 → $80
Current: $76.78
Upside: +4.19%
Trupanion
Aug 20, 2026
Reiterated: Hold
Price Target: $28 → $29
Current: $25.07
Upside: +15.68%
IDEXX Laboratories
Aug 14, 2026
Reiterated: Buy
Price Target: $675
Current: $511.65
Upside: +31.93%
SkinHealth Systems
Aug 11, 2026
Reiterated: Hold
Price Target: $2 → $1
Current: $0.675
Upside: +48.15%
Tandem Diabetes Care
Aug 7, 2026
Reiterated: Hold
Price Target: $22
Current: $16.87
Upside: +30.41%
Aug 7, 2026
Reiterated: Hold
Price Target: $14
Current: $9.54
Upside: +46.75%
Aug 6, 2026
Rated: Buy
Price Target: $225 → $180
Current: $140.60
Upside: +28.02%
Aug 5, 2026
Reiterated: Hold
Price Target: $84 → $95
Current: $84.84
Upside: +11.98%
Jul 31, 2026
Rated: Buy
Price Target: $90 → $95
Current: $89.35
Upside: +6.32%
Jul 30, 2026
Reiterated: Buy
Price Target: $210
Current: $147.61
Upside: +42.27%
Jul 8, 2026
Reiterated: Hold
Price Target: $235
Current: $224.99
Upside: +4.45%
May 11, 2026
Reiterated: Hold
Price Target: $9 → $8
Current: $9.58
Upside: -16.49%
Jan 7, 2022
Reiterated: Buy
Price Target: $10 → $9
Current: $0.67
Upside: n/a
May 8, 2020
Reiterated: Hold
Price Target: $55 → $45
Current: $163.81
Upside: n/a
Jul 23, 2019
Downgraded: Hold
Price Target: $100
Current: $0.0002
Upside: n/a
May 15, 2017
Reiterated: Hold
Price Target: $41 → $47
Current: $239.56
Upside: n/a